SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Identification of gestational diabetes mellitus in European electronic healthcare databases: insights from the ConcePTION project

Mølgaard-Nielsen, D; Mitter, V; Lupattelli, A; Hoxhaj, V; Andaur Navarro, CL; Hayati, S; Lopez-Leon, S; Morris, JK; Geldof, A; Jordan, S; et al. Mølgaard-Nielsen, D; Mitter, V; Lupattelli, A; Hoxhaj, V; Andaur Navarro, CL; Hayati, S; Lopez-Leon, S; Morris, JK; Geldof, A; Jordan, S; Leinonen, MK; Martikainen, V; Manfrini, M; Cammarota, L; Neville, A; Barrachina-Bonet, L; Cavero-Carbonell, C; García-Villodre, L; Caillet, A; Beslay, M; Damase-Michel, C; van Gelder, MMHJ; Nordeng, H (2025) Identification of gestational diabetes mellitus in European electronic healthcare databases: insights from the ConcePTION project. BMJ Open, 15 (10). e102343-e102343. ISSN 2044-6055 https://doi.org/10.1136/bmjopen-2025-102343
SGUL Authors: Morris, Joan Katherine

[img] PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (1MB)
[img] PDF (Supplementary Materials) Supporting information
Download (488kB)
[img] PDF (Figure S1) Supporting information
Download (46kB)
[img] PDF (Figure S2) Supporting information
Download (32kB)

Abstract

Objective To develop and compare algorithms for identifying gestational diabetes mellitus (GDM) across European electronic healthcare databases and evaluate their impact on the estimated prevalence. Design Multi-national cohort study using routinely collected electronic healthcare data Setting National and regional databases in five European countries (Norway, Finland, Italy, Spain and France), in primary and/or secondary care. Participants Pregnancy cohorts resulting in stillbirths or live births between 2009 and 2020, comprising 602 897 pregnancies in Norway, 507 904 in Finland, 374 009 in Italy, 193 495 in Spain and 116 762 in France. Primary and secondary outcomes The primary outcome was the prevalence of GDM identified using six algorithms: (1) Only diagnosis; (2) Diagnosis or prescription; (3) Two diagnoses or prescriptions (2DxRx); (4) Diagnosis including unspecified diabetes in pregnancy or prescription (DxRx broad); (5) Diagnosis excluding pre-existing diabetes in pregnancy or prescription; (6) Registration of GDM in a birth registry (BR). Results The strictest algorithm (2DxRx) resulted in the lowest GDM prevalence, while the broadest (DxRx broad) resulted in the highest, except in France where it was BR. In the Nordic countries, GDM prevalence varied only slightly by algorithm; greater variations were observed in other countries. The prevalence ranged from 3.5% (95% CI: 3.5% to 3.5%) to 4.6% (95% CI: 4.5% to 4.7%) in Norway; 12.1% (95% CI: 12.0% to 12.2%) to 15.8% (95% CI: 15.7% to 15.9%) in Finland, where prevalence was much higher than elsewhere. The prevalence ranged from 1.3% (95% CI: 1.3% to 1.3%) to 5.4% (95% CI: 5.3% to 5.5%) in Italy; 1.6% (95% CI: 1.5% to 1.7%) to 6.2% (95% CI: 6.1% to 6.3%) in Spain; and 1.7% (95% CI: 1.6% to 1.8%) to 5.8% (95% CI: 5.7% to 5.9%) in France. Conclusions In this multinational study, GDM prevalence ranged from 1.3% to 15.8% depending on the algorithm and database. Nordic countries showed smaller differences in prevalence between algorithms, while the other countries showed larger variations, likely due to differences in coding practices, healthcare systems and database coverage.

Item Type: Article
Additional Information: © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Keywords: Diabetes in pregnancy, Electronic Health Records, Pregnancy, Humans, Diabetes, Gestational, Pregnancy, Female, Prevalence, Algorithms, Databases, Factual, Europe, Adult, Electronic Health Records, Cohort Studies, Registries
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: BMJ Open
ISSN: 2044-6055
Language: en
Related URLs:
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
Projects:
Project IDFunderFunder ID
821520Innovative Medicines Initiativehttps://doi.org/10.13039/501100010767
Dates:
Date Event
2025-10-05 Published
2025-09-12 Accepted
URI: https://openaccess.sgul.ac.uk/id/eprint/117963
Publisher's version: https://doi.org/10.1136/bmjopen-2025-102343

Actions (login required)

Edit Item Edit Item